Ruibao Ren

10.8k total citations · 3 hit papers
92 papers, 7.5k citations indexed

About

Ruibao Ren is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ruibao Ren has authored 92 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 47 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in Ruibao Ren's work include Chronic Myeloid Leukemia Treatments (36 papers), Acute Myeloid Leukemia Research (19 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Ruibao Ren is often cited by papers focused on Chronic Myeloid Leukemia Treatments (36 papers), Acute Myeloid Leukemia Research (19 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Ruibao Ren collaborates with scholars based in United States, China and Japan. Ruibao Ren's co-authors include David Baltimore, Bruce J. Mayer, D Baltimore, George B. Cohen, Vincent R. Racaniello, Xiaowu Zhang, Z S Ye, Pramod S. Pandey, Donald Küfe and Surender Kharbanda and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ruibao Ren

90 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Ten-Amino Acid Proline-Rich SH3 Binding Site

1993 1.1k citations Ruibao Ren et al. profile →
Modular binding domains in signal transduction proteins

1995 816 citations Ruibao Ren et al. profile →
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia

2005 763 citations Ruibao Ren Nature reviews. Cancer profile →

Peers

Ruibao Ren

HEMAT

GENET

ONCOL

IMMUN

Victor M. Rivera United States

Stuart H. Orkin United States

Bhushan Nagar Canada

W. Michael Kuehl United States

Gerd A. Blobel United States

Viktor Magdolen Germany

Dirk Heckl Germany

Bruno Calabretta United States

Claude Boucheix France

Wallace Y. Langdon Australia

Victor M. Rivera United States

Ruibao Ren

4.9k ×1.1

1.4k ×0.6

HEMAT

1.1k ×0.9

GENET

2.0k ×1.7

ONCOL

455 ×0.5

IMMUN

Citations per year, relative to Ruibao Ren Ruibao Ren (= 1×) peers Victor M. Rivera

Countries citing papers authored by Ruibao Ren

Since Specialization

Citations

This map shows the geographic impact of Ruibao Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruibao Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruibao Ren more than expected).

Fields of papers citing papers by Ruibao Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruibao Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruibao Ren. The network helps show where Ruibao Ren may publish in the future.

Co-authorship network of co-authors of Ruibao Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Ruibao Ren. A scholar is included among the top collaborators of Ruibao Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruibao Ren. Ruibao Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jiaoyang, Bo Jiao, Zhitong Li, et al.. (2025). Palmitoyltransferase ZDHHC19 regulates histone-to-protamine exchange during spermiogenesis in mice. Science Advances. 11(42). eadv5189–eadv5189.

Wang, Kai, Ming Zhao, Rong Lin, et al.. (2024). The impact of age and number of mutations on the size of clonal hematopoiesis. Proceedings of the National Academy of Sciences. 121(8). e2319364121–e2319364121. 13 indexed citations

Wang, Jinzeng, Xiaoyang Li, Ping Liu, et al.. (2024). A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemia. Signal Transduction and Targeted Therapy. 9(1). 358–358. 1 indexed citations

Li, Donghe, et al.. (2023). Synergism of FAK and ROS1 inhibitors in the treatment of CDH1-deficient cancers mediated by FAK-YAP signaling. International Journal of Biological Sciences. 19(9). 2711–2724. 9 indexed citations

Ning, Nannan, Ziqi Shang, Zhi‐Ping Liu, et al.. (2023). A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling. Cell Death Discovery. 9(1). 453–453. 17 indexed citations

Ma, Tingting, Yongmei Zhu, Bo Jiao, et al.. (2021). IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia. Frontiers of Medicine. 16(3). 403–415. 2 indexed citations

Xiao, Xinhua, Ping Liu, Donghe Li, et al.. (2020). Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition. Journal of Hematology & Oncology. 13(1). 80–80. 15 indexed citations

Li, Xiaoyang, Ya Li, Ruibao Ren, et al.. (2019). Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study. BMC Cancer. 19(1). 819–819. 5 indexed citations

Wu, Min, Jinyan Huang, Jianming Zhang, et al.. (2016). N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation. Molecular Cancer Therapeutics. 16(1). 57–67. 14 indexed citations

10.

Liu, Ping, Ruihong Zhang, Min Wu, et al.. (2015). Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4A. Journal of Hematology & Oncology. 8(1). 132–132. 20 indexed citations

11.

Wang, Yiping, Mengtao Xiao, Xiufei Chen, et al.. (2015). WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation. Molecular Cell. 57(4). 662–673. 224 indexed citations

12.

Du, Tingting, Peng‐Fei Xu, Zhiwei Dong, et al.. (2014). Setdb2 controls convergence and extension movements during zebrafish gastrulation by transcriptional regulation of dvr1. Developmental Biology. 392(2). 233–244. 19 indexed citations

13.

Jagani, Zainab, Keli Song, Jeffery L. Kutok, et al.. (2009). Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors. Cancer Research. 69(16). 6546–6555. 40 indexed citations

14.

Zhang, Sujiang, Liyuan Ma, Qiuhua Huang, et al.. (2008). Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proceedings of the National Academy of Sciences. 105(6). 2076–2081. 129 indexed citations

15.

Ren, Ruibao. (2005). Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia. Nature reviews. Cancer. 5(3). 172–183. 763 indexed citations breakdown →

16.

Dinulescu, Daniela M., Lisa J. Wood, Lei Shen, et al.. (2003). c-CBL is not required for leukemia induction by Bcr-Abl in mice. Oncogene. 22(55). 8852–8860. 12 indexed citations

17.

Ren, Ruibao. (2003). Modeling the dosage effect of oncogenes in leukemogenesis. Current Opinion in Hematology. 11(1). 25–34. 18 indexed citations

18.

Gross, Alec W. & Ruibao Ren. (2000). Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Oncogene. 19(54). 6286–6296. 14 indexed citations

19.

Gross, Alec W., Xiaowu Zhang, & Ruibao Ren. (1999). Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy. Molecular and Cellular Biology. 19(10). 6918–6928. 53 indexed citations

20.

Chen, Mei, Hongyun She, Elizabeth M. Davis, et al.. (1998). Identification of Nck Family Genes, Chromosomal Localization, Expression, and Signaling Specificity. Journal of Biological Chemistry. 273(39). 25171–25178. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact